Racial Differences Seen in Prostate Cancer Care Quality
By Lori Solomon HealthDay Reporter
WEDNESDAY, July 30, 2025 -- Black men with newly diagnosed prostate cancer have lower odds of overtreatment and confirmatory testing when compared with White men, according to a research letter published online July 24 in JAMA Network Open.
Dawson C. Hill, from the University of Michigan in Ann Arbor, and colleagues examined racial differences in confirmatory testing and potential overtreatment in men with newly diagnosed prostate cancer. The analysis included 8,051 men electing for active surveillance and 5,090 unhealthy men at risk for overtreatment identified from a sample of Medicare beneficiaries (2014 to 2019).
The researchers found that Black race was associated with lower odds of undergoing confirmatory testing within 12 months of diagnosis versus White race (adjusted odds ratio, 0.75), yielding a 6.1 percent decrease in confirmatory testing completion. Black race was associated with lower odds of overtreatment among unhealthy men (adjusted odds ratio, 0.86) compared with White race. Overtreatment was less common in Black men versus White men (adjusted difference, 6.1 percent).
"Our study highlights the importance of understanding the nuanced relationship between utilization and prostate cancer care quality when trying to improve care for underserved communities," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Racialized Economic Segregation Linked to Advanced Cancer Diagnosis
FRIDAY, Aug. 1, 2025 -- People living in racially and economically segregated neighborhoods are more likely to be diagnosed with advanced-stage breast and cervical cancer...
New Subtype of Diabetes Identified in Sub-Saharan Africans, Black Americans
FRIDAY, Aug. 1, 2025 -- A new diabetes subtype has been identified in Sub-Saharan Africans and Black Americans, according to a study published online July 21 in The Lancet...
Changes in Missouri Law Linked to Increased Breast Cancer Screening Rates
THURSDAY, July 31, 2025 -- Changes in Missouri law expanding breast cancer screening coverage have led to increased screening rates among Medicaid patients and an increased...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.